Treatment of chronic hepatitis CThe past

• Interferon alfa monotherapy in a dose equivalent to 3 MU tiw for 6-12 months leads to SVR in only 10-15% of patients

• Different types of interferon have similar response rates.

Previous slide

Next slide

Back to first slide

View graphic version